Provisional determination for new COVID treatment

Sabizabulin’s sponsor can now seek provisional registration for the treatment of COVID-19, says the TGA The Therapeutic Goods Administration has announced that it has granted a provisional determination to Adjutor Healthcare Pty Ltd for a new orally-administered medicine, sabizabulin, for the treatment of COVID-19. “The determination means that Adjutor Healthcare is now able to apply